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The purpose of this study was to compare the neurotrophic factor response following
one session of high-intensity exercise, resistance training or both in a cohort of
physically inactive overweight adults aged 18–30 years old. A randomized, parallel-group
clinical trial of 51 men (23.6 ± 3.5 years; 83.5 ± 7.8 kg; 28.0 ± 1.9 kg/m2) who
are physically inactive (i.e., <150min of moderate-intensity exercise per week or
IPAQ score of <600 MET min/week for >6 months) and are either abdominally
obese (waist circumference ≥90 cm) or have a body mass index, BMI ≥25 and
≤30 kg/m2 were randomized to the following four exercise protocols: high-intensity
exercise (4 × 4min intervals at 85–95% maximum heart rate [HRmax] interspersed
with 4min of recovery at 75–85% HRmax) (n = 14), resistance training (12–15
repetitions per set, at 50–70% of one repetition maximum with 60 s of recovery)
(n = 12), combined high-intensity and resistance exercise (n = 13), or non-exercising
control (n = 12). The plasma levels of neurotrophin-3 (NT-3), neurotrophin-4
(also known as neurotrophin 4/5; NT-4 or NT-4/5), and brain-derived neurotrophic
factor (BDNF) were determined before (pre-exercise) and 1-min post-exercise for
each protocol session. Resistance training induced significant increases in NT-3
(+39.6 ng/mL [95%CI, 2.5–76.6; p= 0.004], and NT-4/5 (+1.3 ng/mL [95%CI, 0.3–2.3;
p = 0.014]), respectively. Additionally, combined training results in favorable effects
on BDNF (+22.0, 95% CI, 2.6–41.5; p = 0.029) and NT-3 (+32.9 ng/mL [95% CI,
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12.3–53.4; p = 0.004]), respectively. The regression analysis revealed a significant
positive relationship between changes in BDNF levels and changes in NT-4/5 levels
from baseline to immediate post-exercise in the combined training group (R2 = 0.345,
p = 0.034) but not the other intervention groups. The findings indicate that acute
resistance training and combined exercise increase neurotrophic factors in physically
inactive overweight adults. Further studies are required to determine the biological
importance of changes in neurotrophic responses in overweight men and chronic effects
of these exercise protocols.
Trial Registration: ClinicalTrials.gov, NCT02915913 (Date: September 22, 2016).
Keywords: neurotrophic factors, exercise, obesity, inactivity, plasticity
INTRODUCTION
The neurotrophin family of growth factors, comprised of nerve
growth factors, brain-derived neurotrophic factor (BDNF),
neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5), all
of which were originally defined by their ability to support
the survival, development, and function of neurons (Dechant
and Neumann, 2003). Moreover, a metabotrophic role of
nerve growth factor and BDNF has recently been implicated
in the pathogenesis of metabolic related disorders, sensation,
and energy homeostasis (Hristova, 2013). Likewise, the
BDNF/tyrosine kinase receptor signaling pathway controls
feeding and metabolism, and its dysfunction leads to severe
obesity or subclinical inflammatory diseases such as metabolic
syndrome, insulin resistance, and type 2 diabetes (Tonra et al.,
1999; Nonomura et al., 2001; Cai et al., 2006; Rosenthal and Lin,
2014; Wei et al., 2017).
In contrast to metabolic related disorders-induced BDNF
changes, Mercader et al. (2008) analyzed an NT-4/5 knockout
mouse model and showed that this mice displays reduced food
satiation and hyperphagic behavior resulting in an obese mouse
when fed ad libitum. Furthermore, the infusion of NT-4/5 into
the third ventricle of the brain reversed the obese phenotype,
which suggests that NT-4/5 is involved in the activation of
signaling cascades in the hypothalamic nuclei; these cascades are
responsible for the control of food intake and energy expenditure.
Interestingly, physical exercise (particularly moderate to
vigorous training) is an effective strategy to combat metabolic
disorders due to its ability to influence body composition and
some biomarkers, such as cholesterol and insulin resistance
(Gibala and McGee, 2008; Buch et al., 2017). During high-
intensity exercise (>80% of maximal oxygen intake), significant
increases in neurotrophic factor have been observed (Marston
et al., 2017). In this line, Saucedo-Marquez et al. (2015) showed
Abbreviations: BDNF, brain-derived neurotrophic factor; neurotrophin-3, NT-3;
NT-4/5, neurotrophin-4/5; HIIT, high-intensity interval training; GDNF, glial cell
line-derived neurotrophic factor; TNF-α, tumor necrosis factor alpha; CEMA, in
Spanish at the Centre of Studies in Physical Activity Measurements; RT, resistance
training; WHO, world health organization; HR, heart rate; 1RM, one repetition
maximum; BMI, body mass index; TEM, technical error of measurement; BIA,
bioelectrical impedance analyser; VO2max, maximal oxygen intake.
that after a 20-min single session of either a continuous exercise
protocol (at 70% of maximal work rate) or an high-intensity
interval training (HIIT) protocol (at 90% of maximal work rate
for periods of 1min alternating with 1min of rest), the BDNF
levels were increased compared to the levels at rest. Tonoli
et al. (2015) showed that a combined session of HIIT and
continuous exercise increased serumBDNF and IGF-I levels in 10
participants with type 1 diabetes. Verbickas et al. (2017) showed
that serum BDNF levels were decreased at 1–24 h after 200 drop
jumps. Afzalpour et al. (2015) compared the effects of 6 weeks of
HIIT and continuous training regimens on the levels of BDNF,
glial cell line-derived neurotrophic factor (GDNF) and tumor
necrosis factor alpha (TNF-α) in the rat brain. These authors
showed that both HIIT and continuous training regimens
significantly increased BDNF and GDNF concentrations with
larger increases following HIIT than continuous training.
Other studies report increases in peripheral BDNF following
acute resistance training (RT) (Yarrow et al., 2010; Marston
et al., 2017), whereas others report no change (Correia et al.,
2010; Goekint et al., 2010). These discrepancies can likely be
explained by the wide range of characteristics of the participants
(age, health status, diseases, etc.), study duration, intervention
exercise program (i.e., jumping, treadmill, and/or elliptical,
weight machines), and the extent of change in body composition
across these studies. There are also reports of exercise-induced
changes in NT-3 (Gómez-Pinilla et al., 2001; Johnson and
Mitchell, 2003) and NT-4/5 (Chung et al., 2013) expression
following focal cerebral ischemia or spinal cord injury in rats.
However, there are no reports of exercise-induced changes in
plasma NT-3 or NT-4/5 levels in humans. There is considerable
information available concerning the endocrine response in lean
individuals as a point of reference for future research using an
inactive/overweight model.
Therefore, the aim of the present study was to compare the
acute responses of the neurotrophic factors BDNF, NT-3, and
NT-4/5 prior to and after one session of exercise comprising
HIIT, RT, or both in a cohort of physically inactive overweight
adults aged 18–30 years old. It was hypothesized that the
combined training protocol would induce the highest metabolic
perturbations and therefore the highest hormonal responses to a
greater extent than RT group and HIIT alone.
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METHODS
Study Design and Participants
The BrainFit Study is a single blind, randomized controlled 2
× 2 factorial trial (ClinicalTrials.gov ID: NCT02915913). The
study was approved by the Medical Research Ethics Committee
of The Universidad Nacional de Colombia (Code N◦ 018-
223-16). Fifty-one men (aged 18–30 years), who were inactive
(according to the International Physical Activity Questionnaire,
IPAQ<150min of moderate-intensity exercise per week or IPAQ
score of <600 MET min/week for greater than 6 months),
had abdominal obesity (defined as waist circumference [WC]
≥ 90 cm) or excess weight (defined as BMI ≥25 and ≤30
kg/m2) were recruited from Bogota, Colombia. The latest
International Diabetes Federation/National Heart, Lung, and
Blood Institute/American Heart Association (IDF/NHLBI/AHA-
2009) consensus stated that WC was measured according to
Country/Specific values which, for Latin Americans, were set to
be equal to South Asian parameters, specifically WC ≥90 cm
for males (Alberti et al., 2009). Subjects were recruited between
September 1, 2016, and June 30, 2017. Healthy and inactive
men who were currently not taking drugs, tobacco, or any
other medications were included in this study. A validated
questionnaire, the “FANTASTIC” lifestyle (Ramírez-Vélez and
Agredo, 2012), was used to collect comprehensive information
about substance use via a personal interview with participants.
At the beginning of every session, quality of sleep, smoking,
alcohol, and caffeine consumption, before the experiment were
documented. The final follow-up visit was in July 2017. Inclusion
and exclusion criteria are provided in Table 1.
Recruitment
Consecutive males with either abdominal obesity or excess
weight were recruited from different educational institutions
(Universidad Nacional, CEMA-Universidad del Rosario,
Universidad Santo Tomás, Universidad Manuela Beltrán,
and Universidad de la Sabana) that receive referrals from
both medical consultants and biomedical practitioners in the
capital district of Bogotá and the Cundinamarca Department
in the Andean region (Ramírez-Vélez et al., 2016). Subjects
who are interested in participating were provided additional
information and underwent the following procedures: (i) initially
screened for pre-participation exercise using a cardiovascular
and musculoskeletal checklist; (ii) baseline testing; (iii) a single
isocaloric acute training protocol; and (iv) post-training testing.
All participants were informed of the purpose and risk of the
study before signing an informed consent form.
Blinding and Randomization Methods
Randomization into the four study arms was performed by
CEMA at the University of Rosario, Bogotá, Colombia, using
block randomization with a block size of four. After completing
the baseline measurements, eligible participants were randomly
assigned to either the control or one of the exercise training
groups. Participants were randomly allocated using a computer-
generated randomization code created before the data collection
by an investigator not involved in the assessment or treatment
TABLE 1 | Inclusion/exclusion criteria.
Inclusion criteria Exclusion criteria
a. Inactive: no participation in
supervised exercise more than once a
week for the previous 6 months,
according to the IPAQ score of <600
MET min/week
a. Systemic infections
b. Central obesity: waist
circumference ≥90 cm or excess
weight: body mass index ≥25 and
≤30 kg/m2
b. Weight loss or gain of >10% of
body weight in the past 6 months for
any reason
c. Interested in improving
cardiovascular health and physical
fitness
c. Currently taking medication that
suppresses or stimulates appetite
d. Written informed consent d. Uncontrolled hypertension: systolic
blood pressure 160 mmHg or
diastolic blood pressure 95 mmHg on
treatment
e. Interested in improving
cardiovascular health and physical
fitness
e. Gastrointestinal disease, including
self-reported chronic hepatitis or
cirrhosis, any episode of alcoholic
hepatitis or alcoholic pancreatitis
within past year, inflammatory bowel
disease requiring treatment in the
past year, recent or abdominal
surgery (e.g., gastrostomy)
f. Asthma
g. Diagnosed diabetes (type 1 or 2),
fasting impaired glucose tolerance
(blood glucose 118 mg/dL), or use of
any anti-diabetic medications
h. Currently taking antidepressant,
steroid, or thyroid medication, unless
dosage instable (no change for 6
months)
i. Current exerciser (>30min
organized exercise per week)
j. Indication of unsuitability of current
health for exercise protocol (Physical
Activity Readiness. Questionnaire,
PARQ)
k. Any other conditions which, in
opinion of the investigators, would
adversely affect the conduct of the
trial
of the participants. These procedures are also detailed in the
study operations manual. Assessors were also blinded to each
participant’s treatment allocation.
Preliminary Analysis
Each of the volunteers participated in three randomized trials
(HIIT, RT, HIIT+RT, and control [no exercise]), and the starting
trial was randomized. At 48 h after the start of the training
period, the 1RM was measured for six different exercises: bicep
screw curl, triceps extension, dumbbell side lateral raise, military
press, dumbbell squat, and dumbbell front lunge which was
implemented based on similar procedures (Ramírez-Vélez et al.,
2016). The 1RM was performed in six resistance exercises and
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was conducted between 09:00 and 11:00 a.m.; the highest load of
three attempts per exercise were reported. Total muscle strength
was calculated as the sum of the six exercises. The 50–70% value
of the 1RMwas used to determine the work load during the single
sessions for the experimental group.
Maximal oxygen intake (VO2max) of inactive subjects was
determined 24 h before acute intervention using a maximum
treadmill exercise test (Precor TRM 885, Italy). Subjects
completed an incremental maximal oxygen uptake test on a
treadmill ergometer. A metabolic cart with an on-line gas
collection system (COSMED K5 portable metabolic system,
Rome, Italy) was used to measure VO2max and carbon dioxide
production data, and HR was continuously monitored with a HR
monitor (A3, Polar Elector OY, Finland).
Exercise Training Protocol
The current exercise protocol was based on data derived
from the Cardiometabolic HIIT-RT Study (ClinicalTrials.gov
ID: NCT02715063). Details of methods had been previously
published elsewhere (Ramírez-Vélez et al., 2016), however, the
most relevant information is briefly described below.
1. Control group: Without exercise training.
2. High-intensity interval training (HIIT) group: All HIIT
sessions were preceded with a 5-min warm-up and ended
with a 4-min cooldown at a 65% heart rate maximal until
the subject expended between 400 and 500 kcal. The HIIT
protocol consisted of four bouts of 4-min intervals at 85–
95% HR maximal interspersed with 4min of active recovery
at 75–85% HR maximal. Participants in the HIIT groups
were instructed to reach their target HR for each interval
within the first 2min of the 4min interval. We calculated the
training energy expenditure with the consensus public health
recommendations from the World Health Organization
(WHO, 2004) and the US Department of Health and Human
Services (Physical Activity Guidelines Advisory Committee,
2008). Heart-rate monitors (A3, Polar Elector OY, Finland)
were used to adjust workload to achieve the target heart rate.
In addition, a rating of perceived exertion was also measured
during each exercise session (15–17 during high intensity and
11–13 during recovery), (Figure 1A).
3. Resistance training (RT) group: The RT session was initiated
with ≈12–15 repetitions per set of six exercises that targeted
all the major muscle groups at high intensity. A 60-s recovery
was permitted as many times as needed according to subject’s
weight until the subject expended between 400 and 500
kcal at 50–70% one repetition maximum (1RM). The RT
included both upper and lower body large-muscle exercises
using weight machines (bicep screw curl, triceps extension,
dumbbell side lateral raise, military press, dumbbell squat, and
dumbbell front) (Ramírez-Vélez et al., 2016). Our exercise
structure, is similar to utilized by Church et al. (2016) is
considered moderate to vigorous intense and therefore it
would be expected resulted in increased levels of peripheral
BDNF, (Figure 1B).
4. Combined training (HIIT+RT) group: This group underwent
both the HIIT and RT protocols, as described above, in that
order. Therefore, the energy expenditure associated with the
physical training prescribed for the vigorous intensity group
was≈400–500 kcal/session (Ramírez-Vélez et al., 2016).
Training Intensity and Energy Expenditure
During the Exercise Session
In terms of exercise intensity, the actual intensity values were
reported as the mean of HR measured in the HIIT and combined
groups and as the average value of workload and repetitions
determined in the acute session in RT group. The intensity
of the HIIT or HIIT+RT group was based on the percentage
of each individual’s HRmax derived from a maximal treadmill
test. The exercise training was 100% supervised. Research
staff monitored and recorded compliance with target HR and
energy expenditure during the sessions. Energy expenditure
was estimated during exercise via indirect calorimetry using a
COSMED K5 portable metabolic system (Rome, Italy) assuming
a non-protein respiratory exchange ratio (Graf et al., 2013). It
was expected that the gradual increase in total energy expenditure
would minimize fatigue, soreness, injuries, and attrition.
Blood Draws and Analysis
Participants arrived at the CEMA laboratory between 6:00
and 9:00 following a 10–12 h overnight fast. Participants were
reminded to maintain standardized conditions (i.e., hydrated
state and abstaining from caffeine and alcohol consumption
for 36 h). Blood samples were drawn into a tube containing
∼1.8mg EDTA-K3 per mL blood for plasma measurements and
a tube with polymer gel for serum measurements (Vacutainer,
Becton Dickinson and Company 2017). Samples were handled
according to Clinical Laboratory Improvement Amendments,
which must be followed in order to achieve valid test results
for accurate diagnoses (Centers for Medicare Medicaid Service,
2005). Finally, both samples were stored at −80◦C for the
analysis of plasma biomarkers of neuronal function using surface
plasmon resonance (SPR) biosensors.
Surface Plasmon Resonance (SPR)
Biosensors
SPR allows real-time monitoring of NT-3, NT-4/5, and BDNF
(R&D Systems, Minnesota, USA) (Bustos et al., 2014). In a
typical experiment, the signal reflection, measured at a fixed
angular position, is evaluated as a function of time. The
real-time strategy of quantification involved specific antibodies
to the target proteins. All experiments were carried out at
25◦C using a SPR Biacore 2000 automatic (Biacore, Uppsala,
Sweden). HBS-EB buffer was used as running buffer at 5–
60µg/mL flow. Anti-neurotrophin-3, anti-neurotrophin-4 and
anti-BDNF antibodies were immobilized onto the CM5 sensor
surface at a concentration ranging from 10 to 50µg/mL.
Before immobilization of the antibodies, the sensor surface
was activated via an amino-coupling chemistry kit K AN-
50 Coupling Kit (GE Healthcare, Uppsala, Sweden). For the
immobilization steps, the basic principles of assays using SPR
were applied, such as preconcentration and binding assay with
the analyte. Excess activated carboxyl groups were blocked with
1M ethanolamine hydrochloride (pH 9.5). A reference or control
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FIGURE 1 | Run-in training interventions. (A), HIIT group; (B), RT group. Combined training group were received both the HIIT and RT protocols as described above.
flow cell containing 50µg/mL bovine serum albumin (Sigma-
Aldrich, Saint Louis, MO) at pH 5.0 was used to subtract
the instrument’s systematic noise and drift (i.e., background
response). After each injection of the analyte and standard
samples to the binding assay, an optimal regeneration solution
was injected as described in previous studies (Andersson et al.,
1999; Kuroki and Maenaka, 2011). The percentage of surface
regeneration was estimated using the following equation: [1 –
(Rreg/Ro) × 100]. The complete regeneration was higher than
50%. Standard curves were constructed by diluting standards of
recombinant NT-3, NT-4, and BDNF protein (Bustos et al., 2014).
A range of 20–5,000 ng/ mL was used to obtain the curve (Bustos
et al., 2014). The manufacturer declares intra- and inter-assay
coefficients of variation of <10%.
Body Composition and Anthropometric
Measures
Body fat mass was determined with a multifrequency
bioelectrical impedance analyser (BIA) using tetrapolar
whole body impedance (Model Seca R© mBCA 514 Medical
Body Composition Analyzer, Hamburg, Germany). A detailed
description of the BIA technique can be found in a previous
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study (Rodríguez-Rodríguez et al., 2016). The intra-observer
technical error (% reliability) of the measurements was 95%.
The values of height and body mass were recorded in meters
to the nearest 0.1 cm and 0.1 kg with an electronic height
(Seca R© 274, Hamburg, Germany) and weight scale (Model Seca R©
mBCA 514 Medical Body Composition Analyzer, Hamburg,
Germany). BMI was calculated with the following formula:
BMI = body weight (kg)/height squared (m2) (WHO, 2000).
Waist circumference (WC) was also measured to the nearest
1mm with a flexible steel tape measure (Lufkin W606PM R©,
Parsippany, New Jersey, USA) placed midway between the lowest
rib and the iliac crest while participants were in a standing
position at the end of an exhalation in accordance with the
International Society for the Advancement of Kinanthropometry
guidelines (Marfell-Jones et al., 2012). The technical error of
measurement values was < 2% for all anthropometric variables.
Statistical Analysis
To calculate the required sample size, we used the formula for
the comparison of two means: n = [A + B]2 × 2 × SD2/DIFF2,
where n= the sample size required in each group, SD= standard
deviation of the outcome variable and DIFF= size of the desired
difference between groups. A and B depend on the desired
significance level and desired power, respectively. Using estimates
obtained from the literature (Saucedo-Marquez et al., 2015;
Tonoli et al., 2015), a sample size of eight subjects in each group
was needed to reach a power of 80% to detect a difference in
means in the relative change of BDNF (10%1 after 5min of HIIT
training, assuming an SD of 588 pg/mL using a two-sample t-test
with a 0.05 two-sided significance level). Assuming a drop-out
rate of 20%, the total minimal sample size has been increased to
12 subjects for each group. We believe this sample size is feasible
and realistic based on other experience in experimental studies
(Gómez-Pinilla et al., 2001; Johnson and Mitchell, 2003; Krabbe
et al., 2007; Rasmussen et al., 2009; Seifert et al., 2010; Chung
et al., 2013; Saucedo-Marquez et al., 2015).
Comparisons between differences of mean values of normally
distributed variables between groups of exercise were tested using
linear mixed-effects modeling for repeated measures over time
using BDNF, NT-3, and NT-4 as the dependent variable and
effects for time, group (HIT, RT, HIIT+RT, or control group), and
time by group interaction including their baseline measurement
and VO2max the intervention time as co-variables, following
the same procedures as in the intent-to-treat analyses. The
significance level adopted to reject the null hypothesis was p <
0.05, and effect size for paired comparisons was reported as η2
partial throughout; these values are interpreted as small (≥0.02),
moderate (≥0.13), and large (≥0.26). Regression analyses were
used to examine the relationship between changes in BDNF and
other neurotrophic factors. Finally, goodness-of-fit tests were
performed to determine whether the proportion of participants
who showed higher final neurotrophic levels in each protocol was
equal. Parametric datasets are summarized in text as the mean
(SD), standard error of the mean (SEM) and 95% CI. All analyses
were performed using the SPSS software package (Version 22,
IBM, New York, USA).
RESULTS
Of the 70 participants who entered the run-in phase, 56 (80%)
were randomized. Reasons for pre-randomization exclusion
included excessive BMI, refusal to participate, or a medical
condition (Figure 2). Five additional participants (2 from the
control group, 2 from the RT group, and 1 from the combined
group) were excluded from the blood sample analyses because
their serum was technically inadequate.
Descriptive statistics for each sex group are shown in Table 2.
No significant intergroup baseline differences were observed.
The concentration of BDNF, NT-3, and NT-4/5 at rest
and immediately after the exercise, are presented in Table 3.
The variables analyzed were similar at baseline. RT induced
significant increases in NT-3 (+39.6 ng/mL [95% CI, 2.5–
76.6; p = 0.004], and NT-4/5 (+1.3 ng/mL [95% CI, 0.3–
2.3; p = 0.014]), respectively. Additionally, combined training
results in favorable effects on BDNF (+22.0, 95% CI, 2.6–
41.5; p = 0.029) and NT-3 (+32.9 ng/mL [95% CI, 12.3–53.4;
p = 0.004]), respectively. In the per-protocol analyses, neither
intervention significantly changed BDNF [F(interaction) = 1.412;
η
2 = 0.083], NT-3 [F(interaction) = 1.280; η2 = 0.076], and NT-4/5
[F(interaction) = 0.649; η2 = 0.040].
The regression analysis revealed a significant positive
relationship between changes in BDNF levels and changes in
NT-4/5 levels from baseline to immediate post-exercise in the
combined training group (R2 = 0.345, p= 0.034; Figure 3C) but
not the other intervention groups. Additionally, no relationship
was found between changes in BDNF levels and changes in NT-3
levels (Figures 3A,B,D).
DISCUSSION
The primary findings were that all three exercise protocols
induced greater changes in neurotrophin levels compared to
the levels in the baseline levels; however, the combined and RT
protocols exhibited greater changes in BDNF, NT-3, and NT-
4/5 than the HIIT group. Additionally, we observed a positive
relationship between changes in the BDNF levels and changes
in the NT-4/5 levels from baseline to immediately post-exercise
in the combined training group. These data provide preliminary
evidence regarding the role of acute exercise in increasing
neurotrophic factors in humans (Krabbe et al., 2007; Rasmussen
et al., 2009; Seifert et al., 2010; Saucedo-Marquez et al., 2015) and
confirm the results observed in mice (Gómez-Pinilla et al., 2001;
Johnson and Mitchell, 2003; Chung et al., 2013). In addition, it
also suggests that an concurrent training protocol (high intensity
intermittent exercise followed by strength training) may be more
suitable for influencing neurotrophin levels than HIIT or RT
alone.
Within the training protocols, we observed an 6.8%
(Combined training), and 9.3% (RT) mean increase in plasma
BDNF levels immediately post-exercise when compared with the
baseline values. Studies that analyzed the acute effects of RT
(Correia et al., 2010; Goekint et al., 2010; Yarrow et al., 2010;
Church et al., 2016) or HIIT (Saucedo-Marquez et al., 2015;
Tonoli et al., 2015) showed inconsistent results. Our RT protocol
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FIGURE 2 | The BrainFit Trial Flow Diagram. Those whose blood samples (n = 5) were technically inadequate and not analyzed. BMI, body mass index.
comprised exercises at an intensity between 50 and 70% of 1RM
with 25–30 repetitions per exercise. Compared to the aerobic
protocols, the RT session had relatively large resting periods in
between the efforts. By contrast with our results, several studies
demonstrated that a single RT session did not induce significant
changes in blood BDNF levels in healthy inactive adults (Goekint
et al., 2010; Yarrow et al., 2010). However, Church et al. (2016)
and Marston et al. (2017) reported that the use of a to-fatigue
hypertrophy-based RT protocol provides the necessary stimulus
to increase peripheral serum BDNF levels.
The discrepancies observed between our results and these
findings could be due to the population sampled since BDNF
levels are negatively correlated to weight (Lommatzsch et al.,
2005); therefore, the probability of increases could be greater
in the overweight population included in our study. Regarding
high-intensity exercise or combined exercise, a previous study
in 10 inactive individuals with type 1 diabetes showed that
acute HIIT protocols result in larger increases in serum BDNF
concentrations than acute low- or moderate-intensity exercise
protocols (Tonoli et al., 2015). Therefore, these studies have
shown that various features of exercise stimuli (i.e., intensity,
duration, and mode of activity) can affect BDNF levels. It seems
that exercise and/or training temporarily elevate basal BDNF
levels and possibly upregulate the cellular processing of this factor
(Knaepen et al., 2010). In future studies, it could be interesting to
investigate the effects of an intensive strength protocol on BDNF
levels.
Of particular interest, we observed that changes in BDNF
were significantly related to changes in NT-4/5 levels from
baseline to immediately post-exercise in the combined training
group. In literature, the %1 [BDNF] concentrations after
performing exercise vary from 11.7 to 41% (in both healthy
and clinical populations) (Pedersen et al., 2009; Yarrow et al.,
2010; Marston et al., 2017). These results are very much in line
with results reported by Saucedo-Marquez et al. (2015), who
showed that BDNF levels gradually increased over time, reaching
maximal levels after 20min of exercise and returned to baseline
values after 10min of recovery. However, this finding was also
present in animal studies showing positive relationships between
serum hippocampal NT-3 concentration and distance ran
(R2 = 0.157, p < 0.001) (Johnson and Mitchell, 2003). Similarly,
Chung et al. (2013) suggested that NT-4/5 levels were altered in
response to ischemic injury, and treadmill exercise plays a role
in the changes of the levels of neurotrophins and their receptors.
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TABLE 2 | Baseline participant characteristics by group training.
Characteristics Group training
Control (n = 12) HIIT (n = 14) RT (n = 12) HIIT+RT (n = 13)
Age, y 24.7 (3.4) 24.5 (3.7) 22.8 (3.1) 22.2 (3.4)
Weight, kg 88.6 (8.9) 81.7 (6.7) 83.9 (7.4) 80.6 (6.7)
Height, m 1.75 (0.05) 1.72 (0.05) 1.68 (0.18) 1.69 (0.05)
BMI, kg/m2 28.7 (2.0) 27.4 (1.7) 27.8 (1.3) 28.1 (1.2)
Waist circumference, cm 97.9 (6.3) 95.3 (4.9) 94.1 (4.6) 96.9 (5.8)
Body fat percentage, % 28.7 (4.1) 26.2 (4.3) 27.0 (3.7) 28.1 (3.6)
VO2max, ml·kg·min
−1 41.2 (17.3) 40.6 (16.7) 38.9 (10.5) 37.8 (13.6)
EE during exercise, Kcal – 462.6 (74.9) 460.9 (86.7) 461.7 (59.1)
Bicep screw curl, 1RM 25.6 (11.6) 23.4 (7.9) 21.9 (10.3) 20.9 (6.9)
Triceps extension, 1RM 16.1 (5.7) 16.1 (5.3) 17.1 (4.9) 17.9 (4.0)
Dumbbell side lateral, 1RM 9.0 (1.9) 10.8 (3.6) 8.9 (1.9) 10.2 (3.3)
Military press, 1RM 25.8 (9.4) 23.0 (8.3) 22.8 (13.5) 19.0 (5.1)
Dumbbell squat, 1RM 47.8 (23.0) 55.0 (34.4) 53.3 (14.1) 52.8 (23.5)
Dumbbell front lunge, 1RM 28.4 (7. 7) 28.0 (16.2) 22.7 (6.6) 26.3 (10.7)
Total muscle strength, (kg; total of six exercises) 142.7 (43.7) 156.3 (53.4) 136.5 (34.6) 147.2 (38.5)
BDNF, ng/mL* 176.8 (37.6) 161.1 (24.7) 166.0 (30.5) 189.1 (27.0)
NT-3, ng/mL* 247.5 (20.5) 285.4 (41.5) 315.1 (28.6) 275.3 (38.3)
NT-4/5, ng/mL* 14.3 (1.7) 18.0 (1.7) 16.4 (1.8) 17.4 (1.7)
Data in mean (standard deviation) or (SEM)*. HIIT, high-intensity interval training; RT, resistant training; BMI, body mass index; EE, energy expenditure; VO2max, cardiorespiratory fitness;
1RM, one repetition maximal; BDNF, brain-derived neurotrophic factor; NT-3, neurotrophin-3; NT-4/5, neurotrophin-4/5; (–), not applicable.
However, treadmill exercise-mediated changes in the expression
levels of NT-4/5 and tyrosine kinase B might participate in the
recovery process in rats with brain damage. This supports the
idea that increasing the levels of neurotrophic factors contributes
to functional recovery (Keyvani et al., 2004).
The potential mechanism mediating the higher neurotrophin
(i.e., BDNF) response to the different exercise protocols is
currently unclear. However, BDNF is primarily produced in the
brain, some of which crosses the blood-brain barrier and travels
to the periphery where it can be measured in plasma and serum.
Nevertheless, possible BDNF modulating factors such as lactate,
cortisol, and intensity have been previously proposed. Wrann
et al. (2013) proposed a novel biochemical pathway linking an
exercise-induced secreted factor from skeletal muscle to BDNF
gene expression in the brain, especially in the hippocampus.
Interestingly, then RT or concurrent training protocol (HIIT
followed by RT) would be the ideal protocol for elevating BDNF
levels. On the basis of this model we speculate that skeletal
muscle contractions during combined or RT protocol might be
a possible trigger of this biochemical pathway to induce elevated
BDNF levels in the brain. Another physiological mechanism is
platelets, which have the ability to store BDNF and release it upon
agonist stimulation depending on the specific need of BDNF
in certain tissues (Fujimura et al., 2002). Although it remains
unknown how exercise influences the platelets, one potential
use of BDNF stored in platelets is thought to be in the repair
of exercise-induced muscle damage (Saucedo-Marquez et al.,
2015). However, further research is needed to confirm these
mechanisms, especially in childhood obesity during and after
weight-loss exercise programs.
On the other hand, several lines of evidence support a
hypothesis whereby neurotrophins, especially BDNF (Dmitrzak-
Weglarz et al., 2013), play an essential role in with the
initiation and development of both atherosclerosis andmetabolic
syndrome (Chaldakov et al., 2003). In a previous study
Krabbe et al. (2009) found that plasma levels of BDNF
decreased in humans with type 2 diabetes, independently
of obesity, suggesting that certain metabotrophic deficit due
to hyponeurotrophinemia may operate in this metabopathy.
Matthews et al. (2009) have shown that BDNF appears to be a
major player not only in central metabolic pathways, but also
as a regulator of metabolism in skeletal muscles. Studies of
animal models and humans have shown that reduced expression
of neurotrophins results in the glucose and lipid metabolism
alterations (Tonra et al., 1999; Nonomura et al., 2001; Mercader
et al., 2008; Dmitrzak-Weglarz et al., 2013). In general, studies
have observed a correlation between low serum BDNF levels and
high inflammatory protein levels, increased vascular dysfunction
and more cardiovascular risk factors (Chaldakov et al., 2004;
Dmitrzak-Weglarz et al., 2013). Current evidence indicates
plasma BDNF is a proxy marker of BDNF production in the
brain; however, BDNF can also be synthesized peripherally
(Church et al., 2016). However, there are some gaps in the
literature pertaining to obesity, exercise training, and subsequent
neurotrophin responses (Pedersen et al., 2009).
There are several limitations and strengths that should be
considered with respect to the design and outcomes of this
study. Because this study was designed as a pilot study to
inform the development of more elaborate trials, the sample
size, and intervention duration of acute exercise are modest.
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TABLE 3 | Intent-to-treat analysis of BDNF, NT-3, and NT-4/5 at baseline and changes after acute effect.
Characteristics Mean (SEM 1 change
(P value)
From baseline to acute, Mean (95% CI) F interaction
(η2 partial)
Baseline Acute Within-group change Between-group
difference in change
BDNF, ng/mL
HIIT training, (n = 14) 161.0 (23.1) 172.1 (25) +6.8
(0.134)
11.05 (3.8 to 26.0) – –
RT training, (n = 12) 166.0 (30.6) 181.5 (31.2) +9.3
(0.066)
15.5 (−1.2 to 32.3) – –
Combined training, (n = 13) 189.1 (29.7) 211.2 (34) +11.6
(0.029)
22.0 (2.6 to 41.5) – –
Control group, (n = 12) 176.7 (38.7) 177.9 (38.4) +0.6
(0.804)
1.19 (−11.6 to 9.2) – –
1 Combined vs. 1 control – – – – 20.8 (−0.1 to 41.8) 1.412
(0.083)
1 HIIT vs. 1 control – – – – 9.8 (−10.7 to 30.4)
1 RT vs. 1 control – – – – 14.3 (−35.7 to 7.0)
1 Combined vs 1 HIIT – – – – 11.0 (−9.1 to 31.2)
1 RT vs. 1 HIIT – – – – 4.4 (−16.1 to 25.0)
1 Combined vs. 1 RT – – – – 6.5 (−14.4 to 27.5)
NT-3, ng/mL
HIIT training, (n = 14) 285.3 (46.3) 322.4 (41.5) +12.5
(0.097)
37.4 (−7.7 to 81.7) – –
RT training, (n = 12) 315.1 (28.6) 354.6 (28.6) +13.0
(0.038)
39.6 (2.5 to 76.6) – –
Combined training, (n = 13) 275.2 (33.7) 308.1 (38.9) +11.9
(0.004)
32.9 (12.3 to 53.4) – –
Control group, (n = 12) 247.4 (26.4) 250.0 (25.3) +1.0
(0.638)
2.5 (−8.9 to 14.0) – –
1 Combined vs 1 control – – – – 30.4 (−12.4 to 73.2) 1.280
(0.076)
1 HIIT vs 1 control – – – – 34.5 (−7.5 to 76.5)
1 RT vs 1 control – – – – 37.0 (−6.5 to 80.7)
1 Combined vs 1 HIIT – – – – −4.1 (−45.3 to 37.0)
1 RT vs 1 HIIT – – – – 2.5 (−39.5 to 44.6)
1 Combined vs 1 RT – – – – −6.6 (−49.5 to 36.1)
NT−4/5, ng/mL
HIIT training, (n = 14) 17.9 (2.56) 18 (2.32) +0.5
(0.870)
0.1 (−1.5 to 1.8) – –
RT training, (n = 12) 16.4 (2.0) 17.5 (2.4) +6.7
(0.014)
1.3 (0.3 to 2.3) – –
Combined training, (n = 13) 17.3 (1.9) 18.9 (2.5) +9.2
(0.246)
1.5 (−1.2 to 4.3) – –
Control group, (n = 12) 14.2 (2.3) 14.8 (2.5) +4.2
(0.175)
−0.6 (−0.3 to 1.5) – –
1 Combined vs 1 control – – – – 0.9 (−1.4 to 3.3) 0.649
(0.040)
1 HIIT vs 1 control – – – – −0.4 (−2.8 to 1.9)
1 RT vs 1 control – – – – 0.7 (−1.7 to 3.2)
1 Combined vs 1 HIIT – – – – 1.4 (−0.8 to 3.7)
1 RT vs 1 HIIT – – – – 1.2 (−1.1 to 3.5)
1 Combined vs 1 RT – – – – 0.2 (−2.1 to 2.6)
Data in standard error of the mean (SEM) or (95% CI). HIIT, high–intensity interval training; RT, resistant training; BDNF, brain–derived neurotrophic factor; NT-3, neurotrophin-3; NT-4/5,
neurotrophin-4/5; (–), not applicable; 1, within–group change. η2 partial are interpreted as small (≥0.02), moderate (≥0.13), and large (≥0.26).
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FIGURE 3 | The regression analysis revealed a significant positive relationship between changes in BDNF levels and changes in NT-4/5 levels from baseline to
immediate post-exercise in the combined training group (R2 = 0.345, p = 0.034; C). Additionally, no relationship was found between changes in BDNF levels and
changes in NT-3 levels (A,B,D).
This study was performed with physically inactive individuals,
which could complicate the generalization of results to a more
active overweight population; also, the study was performed with
volunteers, which could lead to sampling bias. While our results
argue that this level of physical activity is feasible for many, it
remains to be seen whether the reported duration is the most
efficacious.
To our knowledge, this is the first study to examine whether
HIIT, RT, or HIIT+RT elicit different effects on plasma levels
of NT-3, NT-4/5, and BDNF in inactive overweight adults.
Interestingly, despite this evidence, there are few clinical trials
that have directly evaluated the effects of sustained exercise
regimens on the brain health of inactive adults (Saucedo-
Marquez et al., 2015; Church et al., 2016; Barha et al., 2017;
Dinoff et al., 2017). The strategy immobilized antibodies onto
sensor surfaces for quantification of protein using biosensors,
which is more accurate and fast compared to traditional
assays (Heinrich et al., 2010; Wöllner et al., 2010; Hu et al.,
2013; Tam et al., 2017). The determination of levels of
neurotrophins is usually performed by ELISA immunoassays;
however, the use of biosensors opens a new possibility in
obtaining results in real time, label free with a high sensitivity and
specificity.
CONCLUSION
Our findings indicate that the use of several exercise protocols
(i.e., fatigue hypertrophy-based RT or combined training)
provides the necessary stimuli to increase peripheral plasma
neurotrophin levels among inactive overweight individuals.
Based on our findings, however, the use of concurrent training
may be considered in exercise programs to enhance the
possibility of a potential metabotropic benefit for individuals
due to increased expression of neurotrophic factors. Additional
longitudinal studies should be performed to establish the
effects of exercise and training on cognitive function in
overweight adults over the long term.
NEW AND NOTEWORTHY
Identifying the training regimen that has the most beneficial
effects on each parameter could potentially lead to enhanced
precision in prescribing exercise training intensity to achieve
optimal outcomes in this population.
The present study demonstrates that that acute resistance
training and combined exercise increase neurotrophic factors
in physically inactive overweight adults. Not all neurotrophic
factors measured responded the same to this type of exercise,
suggesting different regulatory mechanisms and time courses for
induction.
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